Department of Urology, University Hospital of Leuven
BJMO - volume 13, issue 7, november 2019
C. Soenens MD, G. De Meerleer MD, PhD, M. Albersen MD, PhD, H. Van Poppel MD, PhD, B. Beuselinck MD, PhD
Based on a case report of a 47-year old male with primary bone metastatic renal cell carcinoma, the current treatment options are reviewed in this article.
(BELG J MED ONCOL 2019;13(7):305–8)